Abnormalities of the p53 gene in juvenile myelomonocytic leukaemia

British Journal of Haematology

Volumn 106, Issue 4, 1999, Pages 980-986

  Miyauchi, Jun ^a   Asada, Minoru ^a   Tsunematsu, Yukiko ^a   Kaneko, Yasuhiko ^b   Kojima, Seiji ^c   Mizutani, Shuki ^a  

^a NATIONAL CHILDREN S HOSPITAL   (Japan)

^b Saitama Cancer Centre Hospital   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

Author keywords

Blast crisis; CML; JCML; Juvenile myelomonocytic leukaemia; p53

Indexed keywords

CELL DNA;

ARTICLE; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE REARRANGEMENT; HUMAN; MYELOMONOCYTIC LEUKEMIA; ONCOGENE N RAS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0032850075     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01634.x     Document Type: Article

References (47)

1. Ahuja, H., Bar-Eli, M., Advani, S.H., Benchimol, S. & Cline, M.J. (1989) Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia. Proceedings of the National Academy of Sciences of the United Stales of America, 86, 6783-6787.
2. Ahuja, H., Bar-Eli, M., Arlin, Z., Advani, S., Allen, S.L., Goldman, J., Snyder, D., Foti, A. & Cline, M. (1991) The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia. Journal of Clinical Investigation, 87, 2042-2047.
3. Aricò M., Biondi, A. & Pui, C.-H. (1997) Juvenile myelomonocytic leukemia, Blood, 90, 479-488.
4. Bernstein, R. (1998) Cytogenetics of chronic myelogenous leukemia. Seminars in Hematology, 25, 20-34.
5. Boguski, M.S. & McCormick, E (1993) Proteins regulating ras and its relatives. Nature, 366, 643-654.
6. Brodeur, G.M. Dow, L.W. & Williams, D.L. (1979) Cytogenetic features of juvenile chronic myelogenous leukemia. Blood, 53, 812-819.
7. Busque, L., Gilliland, D.G., Prchal, J.T., Sieff, C.A., Weinstein, H.J., Sokol, J.M., Belickova, M., Wayne, A.S., Zuckerman, K.S., Sokol, L., Castleberry, R.P. & Emanuel, P.D. (1995) Clonality in juvenile chronic myelogenous leukemia, Blood, 85, 21-30.
8. Castro-Malaspina, H., Schaison, G., Passe, S., Pasquier, A., Berger, R., Bayle-Weisgerber, C., Miller, D., Seligmann, M. & Bernard, J. (1984) Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer, 54, 675-686.
9. Emanuel, P.D., Shannon, K.M. & Castleberry, R.P. (1996) Juvenile myelomonocytic leukemia: molecular understanding and prospects for therapy. Molecular Medicine Today, 2, 468-475.
10. Feinstein, E., Cimino, G., Gale, R.P., Alimena, G., Berthier, R., Kishi, K., Goldman, J., Zaccaria, A., Berrebi, A. & Canaani, E. (1991) p53 in chronic myelogenous leukemia in acute phase. Proceedings of the National Academy of Sciences of the United States of America, 88, 6293-6297.
11. Freedman, M.H., Estrov, Z. & Chan, H.S.L. (1988) Juvenile chronic myelogenous leukemia. American Journal of Pediatric Hematology/Oncology, 10, 261-267.
12. Gaidano, G., Ballerini, P., Gong, J.Z., Inghirami, G., Neri, A., Newcomb, E.W., Magrath, I.T., Knowles, D.M. & Dalla-Favera, R. (1991) p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 88, 5413-5417.
13. Gaidano, G., Guerrasio, A., Serra, A., Carozzi, F., Cambrin, G.R., Petroni, D. & Saglio, G. (1993) Mutations in the p53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders. Leukemia, 7, 946-953.
14. Goelz, S.E., Hamilton, S.R. & Vogelstein, B. (1985) Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochemical and Biophysical Research Communications, 130, 118-126.
15. Guinn, B.-A. & Mills, K.I. (1997) p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia. Leukemia and Lymphoma, 26, 211-226.
16. Hayashi, K. (1991) PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods and Applications, 1, 34-38.
17. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C.C. (1991) p53 mutations in human cancers. Science, 253, 49-53.
18. Imamura, J., Miyoshi, I. & Koeffler, H.P. (1994) p53 in hematopoietic malignancies, Blood, 84, 2412-2421.
19. Inoue, S., Shibata, T., Ravindranath, Y. & Gohle, N. (1987) Clonal origin of erythroid cells in juvenile chronic myelogenous leukemia. Blood, 69, 975-976.
20. Isobe, M., Emmanuel, B.S., Givol, D., Oren, M. & Croce, C.M. (1986) Localisation of gene for human p53 tumour antigen to bank 17p13. Nature, 320, 84-85.
21. ras. Blood, 84, 3435-3439.
22. Kaneko, Y., Maseki, N., Sakurai, M., Shibuya, A., Shinohara, T., Fujimoto, T., Kanno, H. & Nishikawa, A. (1989) Chromosome pattern in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis. Leukemia, 3, 36-41.
23. Kelman, Z., Prokocimer, M., Peller, S., Kahn, Y., Rechavi, G., Manor, Y., Cohen, A. & Rotter, V. (1989) Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia. Blood, 74, 2318-2324.
24. Lau, R.C., Squire, J., Brisson, L., Kamel-Reid, S., Grunberger, T., Dubé, L., Letarte, M. Shannon, K. & Freedman, M.H. (1994) Lymphoid blast crisis of B-lineage phenotype with monosomy 7 in a patient with juvenile chronic myelogenous leukemia (JCML). Leukemia, 8, 903-908.
25. Luna-Fineman, S., Shannon, K.M. & Lange, B.J. (1995) Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood, 85, 1985-1999.
26. Miles, D.K., Freedman, M.H., Stephens, K., Pallavicini, M., Sievers, E., Weaver, M., Grunberger, T., Thompson, P. & Shannon, K.M. (1996) Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders. Blood, 88, 4314-4320.
27. Miller, C., Mohandas, T., Wolf, D., Prokocimer, M., Rotter, V. & Koeffler, H.P. (1986) Human p53 gene localized to short arm of chromosome 17, Nature, 319, 783-784.
28. Miyauchi, J., Asada, M., Sasaki, M., Tsunematsu, Y., Kojima, S. & Mizutani, S. (1994) Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood, 83, 2248-2254.
29. Niemeyer, C.M., Arieò, M., Basso, C., Biondi, A., Rajnoldi, A.C., Creutzig, U., Haas, O., Harbott, J., Hasle, H., Kerndrup, G., Locatelli, F., Mann, O., Stollmann-Gibbels, B., van't Veer-Korthof, E.Th., van Wering, E. & Zimmermann, M. (1997) Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases, Blood, 89, 3534-3543.
30. Nigro, J.M., Baker, S.J., Preisinger, A.C., Jessup, J.M., Hostetter, R., Cleary, K., Bigner, S.U., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F.S., Weston, A., Modali, R., Harris, C.C. & Vogelstein, B. (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-708.
31. Orita, M., Iwahana, H., Kanuzawa, H., Hayashi, K. & Sckiya, T. (1989a) Detection of polymorphism of human DNA by gel electrophoresis as single strand conformation polymorphism. Proceedings of the National Academy of Sciences of the United States of America, 86, 2766-2770.
32. Orita, M., Suzuki, Y., Sckiya, T. & Hayashi, K. (1989b) Rapid and sensitive detection of point mutations and DNA polymorphism using polymerase chain reaction. Genomics, 5, 874-879.
33. ARF links the tumour suppressor p53 to Ras. Nature, 395, 125-126.
34. Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92, 713-723.
35. Preudhomme, C. & Fenaux, P. (1997) The clinical significance of mutations of the P53 tumour suppressor gene in haematological malignancies. British Journal of Haematology, 98, 502-511.
36. Privitera, E., Schirò, R., Longoni, D., Ronchi, A., Rambaldi, A., Bernasconi, S., Ottolenghi, S., Masera, G. & Biondi, A. (1995) Constitutive expression of GATA-I, EPOR, α-globlin, and δ-globlin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia. Blood, 86, 323-328.
37. Puchkova, G.P., Prigogina, E.L., Fleischmann, E.W., Drosdova, T.S., Mayakova, S.A. & Peterson, I.S. (1983) Chromosome abnormalities in chronic myeloid leukemia in children. Human Genetics, 64, 257-262.
38. Quelle, D.E., Zindy, F., Ashmun, R.A. & Sherr, C.J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encodes two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000.
39. Shannon, K.M., O'Connell, P., Martin, G.A., Paderanga, D. Olson, K., Dinndorf, P. & McCormick, F. (1994) Loss of the normal NFI allale from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. New England Journal of Medicine, 330, 597-601.
40. Side, L., Taylor, B., Cayouette, M., Conner, E., Thompson, P., Luce, M. & Shannon, K. (1997) Homozygous inactivation of the NFI gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. New England Journal of Medicine, 336, 1713-1720.
41. Side, L.E., Emanuel, P.D., Taylor, B., Franklin, J., Thompson, P., Castleberry, R.P. & Shannon, K.M. (1998) Mutations of the NFI gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood, 92, 267-272.
42. Soussi, T., Legros, Y., Lubin, R., Ory, K. & Schlichtholz, R. (1994) Multifactorial analysis of p53 alteration in human cancer: a review. International Journal of Cancer, 57, 1-9.
43. Toren, A., Mandel, M., Amariglio, N., Hakim, Y., Brok-Simoni, F., Rechavi, G., Neumann, Y. & Ramot, R. (1991) Lack of ber rearrangement in juvenile chronic myeloid leukemia. Medical and Pediatric Oncology, 19, 493-495.
44. Wada, H., Asada, M., Nakazawa, S., Itoh, H., Kobayashi, Y., Inouc, T., Fukumuro, K., Chan, L.C., Sugita, K., Hanada, R., Akuta, N., Kobayashi, N. & Mizutani, S. (1994) Clonal expansion of p53 mutant cells in leukemia progression in vitro. Leukemia, 8, 53-59.
45. Xu, G., O'Connell, P., Viskochil, D., Cawthon, K., Robertson, M., Culver, M., Dunn, D., Stevens, J., Gesteland, R., While, R. & Weiss, R. (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell, 62, 599-608.
46. Zakut-Houri, R., Bienz-Tadmor, B., Givol, D. & Oren, M. (1985) Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO Journal, 4, 1251-1255.
47. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J. & Roussel, M.F. (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes and Development, 12, 2424-2433.